Author

M. Frigault

Observed names: M. J. Frigault, M.J. Frigault, Michael J. Frigault

Institutions: Harvard University, Massachusetts General Hospital

Observed institutions: Harvard University, Massachusetts General Hospital

OpenAlex ID: A5113060234

Multicenter, Real-World Study in Patients with R/R Large B-Cell Lymphoma (LBCL) Who Received Lisocabtagene Maraleucel (liso-cel) in the United States (US)

2023 · Jennifer L. Crombie, Loretta J. Nastoupil, et al. · Blood · 17

Op0202 Reset-sle: Clinical Trial Evaluating Rese-cel (resecabtagene Autoleucel), a Fully Human, Autologous 4-1bb Anti-cd19 Car T Cell Therapy in Non-renal Sle and Lupus Nephritis

2025 · S. Sheikh, V. Derebail, et al. · Annals of the Rheumatic Diseases · 9

RELIEF, a Phase 2, Multicenter Clinical Trial to Achieve Donor Hematopoietic Chimerism and Immunosuppression-Free Tolerance After Living Donor Kidney Transplantation

2025 · E. Fuchs, G. Hil, et al. · American Journal of Transplantation · 2

113 | Can Salvage Radiotherapy Achieve Durable Local Control in Relapsed/refractory Large B‐cell Lymphoma Post‐car T Failure?

2025 · H. Ababneh, A. Ng, et al. · Hematological Oncology · 1

620O CART-ddBCMA for multiple myeloma: Interim results from phase I study

2022 · M. Frigault, J. Rosenblatt, et al. · Annals of Oncology · 1

458 | Optimizing Post–chimeric Antigen Receptor T Cell Monitoring: Evidence Across Lisocabtagene Maraleucel Pivotal Clinical Trials and Real‐world Experience

2025 · M. Kamdar, M. Shadman, et al. · Hematological Oncology

406 | Combining Bispecifics and Radiation for Rel/ref Hematologic Malignancies: Friend or Foe?

2025 · H. Ababneh, A. Yee, et al. · Hematological Oncology

450 | 5‐5‐5 Abrt (adaptive Bridging Radiation Therapy)—artificial Intelligence Enters the Car (‐t) in Relapsed/refractory Large B‐cell Lymphoma: Updated Analysis

2025 · H. Ababneh, A. Ng, et al. · Hematological Oncology

140 | Phase 2 Trial of Lisocabtagene Maraleucel (liso‐cel) in Combination With Acalabrutinib in Relapsed/refractory Large B‐cell Lymphomas (lbcl)

2025 · P. C. Johnson, J. E. Arnason, et al. · Hematological Oncology

Multi-Institutional Update on Salvage Radiation Therapy in Relapsed/Refractory Large B Cell Lymphoma Patients in Post-CAR T Cell Therapy Failure

2024 · H. Ababneh, A. Ng, et al. · International Journal of Radiation Oncology*Biology*Physics

Multi-Institutional Update on Bridging Radiotherapy in Relapsed or Refractory Large B-Cell Lymphoma Patients Prior to CAR T-Cell Therapy

2024 · H. Ababneh, A. Ng, et al. · International Journal of Radiation Oncology*Biology*Physics

Radiation Therapy as a Bridging and Salvage Strategy in Patients With Relapsed or Refractory Multiple Myeloma Undergoing Bcma‐targeted Car T‐cell Therapy

2023 · H. S. Ababneh, A. J. Yee, et al. · Hematological Oncology

Works count: 12

Citation count: 30

H-index: 2

I10-index: 1